Yamada T - Search Results

1

Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.

Yamada T, Saito M, Mase T, Hara H, Nagaoka H, Murase K, Tomioka K. Yamada T, et al. Lipids. 1991 Dec;26(12):1179-83. doi: 10.1007/BF02536527. Lipids. 1991. PMID: 1668114

2

2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. II. Structure-activity relationships and active configuration of 2-(3-pyridyl)thiazolidine-4-carboxamides as platelet-activating factor receptor antagonists.

Suzuki T, Nagaoka H, Kondo Y, Takahashi T, Takeuchi M, Hara H, Saito M, Yamada T, Tomioka K, Hamada M, Mase T. Suzuki T, et al. Among authors: yamada t. Chem Pharm Bull (Tokyo). 1998 Sep;46(9):1468-73. doi: 10.1248/cpb.46.1468. Chem Pharm Bull (Tokyo). 1998. PMID: 9775441

3

2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. III.) Synthesis of metabolites and metabolism of 2-(3-pyridyl)thiazolidine-4-carboxamides YM461 and YM264 as platelet-activating factor (PAF) receptor antagonists.

Suzuki T, Nagaoka H, Hara H, Takeuchi M, Saito M, Yamada T, Tomioka K, Matsumoto H, Takanuki K, Mase T. Suzuki T, et al. Among authors: yamada t. Chem Pharm Bull (Tokyo). 1999 Feb;47(2):165-70. doi: 10.1248/cpb.47.165. Chem Pharm Bull (Tokyo). 1999. PMID: 10071851

4

Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat.

Yamada T, Tomioka K, Horie M, Sakurai Y, Nagaoka H, Mase T. Yamada T, et al. Biochem Biophys Res Commun. 1991 Apr 30;176(2):781-5. doi: 10.1016/s0006-291x(05)80253-0. Biochem Biophys Res Commun. 1991. PMID: 2025290

5

Pharmacological properties of YM264, a potent and orally active antagonist of platelet-activating factor.

Yamada T, Tomioka K, Saito M, Horie M, Mase T, Hara H, Nagaoka H. Yamada T, et al. Arch Int Pharmacodyn Ther. 1990 Nov-Dec;308:123-36. Arch Int Pharmacodyn Ther. 1990. PMID: 2099131

6

Pharmacological properties of YM-11124, a selective immunosuppressive agent for cell-mediated immunity.

Tomioka K, Yamada T, Mase T, Murase K. Tomioka K, et al. Among authors: yamada t. Pharmacology. 1989;39(1):28-38. doi: 10.1159/000138568. Pharmacology. 1989. PMID: 2531424

7

Pharmacological properties of the orally active leukotriene antagonist [[5-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propyl]thio]-1,3,4- thiadiazol-2-yl]thio]acetic acid.

Tomioka K, Yamada T, Mase T, Hara H, Murase K. Tomioka K, et al. Among authors: yamada t. Arzneimittelforschung. 1988 May;38(5):682-5. Arzneimittelforschung. 1988. PMID: 3415708

8

2-(3-Pyridyl)thiazolidine-4-carboxamides. 1. Novel orally active antagonists of platelet-activating factor (PAF).

Nagaoka H, Hara H, Suzuki T, Takahashi T, Takeuchi M, Matsuhisa A, Saito M, Yamada T, Tomioka K, Mase T. Nagaoka H, et al. Among authors: yamada t. Chem Pharm Bull (Tokyo). 1997 Oct;45(10):1659-64. doi: 10.1248/cpb.45.1659. Chem Pharm Bull (Tokyo). 1997. PMID: 9353894

9

[Effects of YM-13650 on type I to type IV allergic reactions and immune responses in animals].

Yamada T, Tomioka K, Mase T, Murase K. Yamada T, et al. Nihon Yakurigaku Zasshi. 1991 Feb;97(2):75-84. doi: 10.1254/fpj.97.2_75. Nihon Yakurigaku Zasshi. 1991. PMID: 1829062 Japanese.

10

Isolated tissue and binding studies of YM-17690, a novel and non-analogous leukotriene agonist.

Tomioka K, Yamada T, Teramura K, Terai M, Hidaka K, Mase T, Hara H, Murase K. Tomioka K, et al. Among authors: yamada t. J Pharm Pharmacol. 1987 Oct;39(10):819-24. doi: 10.1111/j.2042-7158.1987.tb05124.x. J Pharm Pharmacol. 1987. PMID: 2891819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,224 results

Search Page

Filters